Healthcare industry

Article - 03/04/2019

HKK Bionics empowers hand gripping functions

A spin-off from the Ulm University of Applied Sciences is aiming to provide people whose hands have been paralysed due to accident or illness with a new kind of orthopaedic aid. Dominik Hepp and Tobias Knobloch are currently starting serial production of a hand orthosis prototype. The two medical engineers from Ulm, who founded HKK Bionics GmbH in 2017, plan to commence final tests in 2019.

Dossier - 04/07/2011

Implants of the future: bioactive, corrosion-resistant and antibacterial

People’s life expectancy is increasing due to constantly improving medical treatment. One result of this is the greater wear of joints, which then need to be replaced with implants. Increased life expectancy means that the implants remain in the body for much longer and therefore need to be longer lasting. The revision rate of implant materials used in clinical practice is still as much as 10 per cent, particularly in the case of hip and knee…

Press release - 29/03/2011

Freiburg Regional Council to fund MedicalMountains cluster initiative

The Freiburg Regional Council has granted MedicalMountains AG funds totalling 405,000 euros for establishing a professional management structure for the Tuttlingen-based medical technology cluster. District President Julian Würtenberger awarded the 405,000-euro grant to Dieter Teufel, president of the Schwarzwald-Baar-Heuberg Chamber of Industry and Commerce and representative of the Tuttlingen-based cluster, in which BIOPRO Baden-Württemberg…

The German Medical Technology Association BVMed is hoping that the new information campaign MedTech-Compass will promote transparent and effective cooperation between the industry medical institutions and physicians.

Article - 06/06/2011

Knowledge transfer depends on the application of learning

The ability of scientists from different disciplines to understand each other as well as excellent communication skills play an ever-increasing role in the transfer of knowledge from academic research to industry. Vice president of research at the Konstanz University of Applied Sciences HTWG Professor Gunter Voigt explains how academia and industry work together and also highlights the conditions that are necessary for such cooperations to lead…

Press release - 30/09/2011

Blood Vessels from Your Printer

Researchers have been working at growing tissue and organs in the laboratory for a long time. These days, tissue engineering enables us to build up artificial tissue, although science still hasn’t been successful with larger organs. Now, researchers at Fraunhofer are applying new techniques and materials to come up with artificial blood vessels in their BioRap project that will be able to supply artificial tissue and maybe even complex organs in…

Press release - 08/03/2010

Innovative microsystems – injection-moulded and printed

Up-to-date injection moulding and printing methods can now be used to produce microtechnical components and entire functional units inexpensively and with the highest possible precision. Refined processing, coating and manufacturing techniques can make the serial production of microsystems considerably easier. Moreover, microsensors are increasingly being used as multifunctional units in the automotive, laboratory, medical and automation…

Press release - 06/07/2012

Medicyte is receiving 4.2 Mio Euros from the European Union Seventh Framework Programm

Medicyte, The Electrospinning Company and the Universities of Manchester and Pisa launch a European wide unique project with the aim to design a biomimetic bioartificial liver (Re-Liver). The company GABO:mi ensures professional project management. Research is receiving 4.2 Mio Euros from the European Union Seventh Framework Programme.

Press release - 11/10/2012

Novalung GmbH receives EU grant for the development of a cell-coated artificial lung

The AmbuLung (Ambulatory Bioartificial Lung) project is a milestone in the history of artificial organs and is being subsidized by the EU with a total of 5.6 Million Euros - 3 Million Euros will go to Novalung as the Coordinator of the European development consortium. The joint developmental goal is the AmbuLung, which will allow patients to remain awake, mobile and active despite lung failure. The core innovation within the framework of the…

Press release - 08/01/2011

Sense2care - new dimension of blood gas analysis systems

Established in August 2010 at the Natural and Medical Sciences Institute at the University of Tübingen (NMI) in Reutlingen, sense2care is an innovative medical technology company. The High-Tech Foundation Fund has now awarded sense2care a total of €500,000 for investing in the development of miniaturised systems to monitor critically ill patients in the operating theatre and in intensive care.

SHS Gesellschaft für Beteiligungsmanagement has received capital commitments of over €90 million in its fifth fund's first closing. The fifth generation of SHS funds is also focused on the life sciences and medical technology sector, and thus on the growing global healthcare market with innovative and strong players, especially in Germany and Switzerland.

Press release - 22/02/2010

AgenoLab GmbH: Improved quality of life for patients with chronic wounds

Since its foundation three years ago, AgenoLab GmbH & Co. KG in Stuttgart has become a leading service provider in the area of life sciences and biotechnology. The company’s cell culture technology unit focuses on the preparation of cells that can largely eliminate the need for animal testing. In the area of regenerative medicine, AgenoLab GmbH concentrates on the growth of skin cells as transplants for patients suffering from burns and…

Press release - 22/03/2011

Bringing artifical vision clinical trials to US

Retina Implant AG Partners with Wills Eye Institute to Bring Artificial Vision Clinical Trials to the United States. Wills Eye to be the Primary Investigation Site to Offer the Subretinal Approach to Retinitis Pigmentosa Patients.

Press release - 05/04/2011

HARTMANN continues its success

Profitability improved despite difficult market conditions: In fiscal year 2010, HARTMANN continued its profitable growth despite unfavorable market conditions, building on its strong sales performance in the previous year. The company was confronted with increasing budget restrictions in the health systems and substantially higher raw material and logistics costs.

As a 100% affiliate of the Baden-Württemberg government, BIOPRO Baden-Württemberg GmbH provides targeted support to the pharmaceutical industry and the biotechnology and medical technology sectors as well as supporting the development of a bioeconomy.

Dr. Annette Schavan the Federal Minister of Education and Research visited the famous university town of Tübingen to gain a first-hand impression of the bioregions vast potentials in the fields of biotechnology and medical technology.

Press release - 26/11/2010

Singapore meets Baden-Württemberg: biotechnology and medical technology companies exchange views

Several biotechnology and medical technology companies from Baden-Wüttemberg and Singapore interested in international cooperation met in Stuttgart on 19th November 2010. The event was organised by SRING Singapore Enterprise and BIOPRO Baden-Württemberg GmbH.

Article - 23/03/2017

CeMIT – professional innovation management for the medical device sector

With the establishment of the Centrum für Medizintechnische Innovationen Tübingen, or CeMIT, the University Hospital of Tübingen is building a bridge between hospitals and medical device companies, which share the aim to develop new and better medical technology products and methods. Partners from small and medium-sized companies are expected to particularly benefit from the services that CeMIT provides and the guidance it can offer in finding…

The Baden-Württemberg healthcare industry – a recession-proof employer that has strong ties with the region - is of key importance for the state. It comprises the biotechnology and medical technology sectors and the pharmaceutical industry. In 2019, the industry with 98,619 employees generated revenues of over 25 billion euros.

Article - 27/05/2009

Raimund Hibst brings laser into dental practices

Nowadays, in many dental practices drills are no longer used to remove caries – much to the patients’ delight. Such practices have replaced drills with lasers, a virtually painless method, with low noise levels and which does not require a local anaesthetic. This is all thanks to the work of Raimund Hibst, a physicist from the ILM in Ulm who has spent many years turning research findings into health market applications, in cooperation with…

The 14th Biotech Finance Forum offered selected biotechnology and medical technology companies from all over Europe the opportunity of an exclusive meeting with internationally operative investors from the venture capital VC scene.

The Albstadt-Sigmaringen University of Applied Sciences was the first to offer a pharmaceutical technology course back in 19871988. The course has become a great success and the graduates are sought after in both the pharmaceutical and medical technology industries.

Industry report 2018 - 27/09/2018

The healthcare industry – the innovation driver of the 21st century: opportunities and challenges

BIOPRO Baden-Württemberg’s new industry report entitled "The Healthcare Industry 2018: Facts and Figures for Baden-Württemberg" has just been published in both German and English. The topic neatly dovetails with the state’s political activities. An evaluation of the region carried out on behalf of the Baden-Württemberg government has clearly recognised the importance of the healthcare sector as a driver of innovation.

Press release - 16/11/2015

The Baden-Württemberg healthcare industry – a strong economic power

(Stuttgart – 16th November 2015) BIOPRO Baden-Württemberg has just published its latest analysis of the Baden-Württemberg healthcare industry including comprehensive facts and figures. Baden-Württemberg continues to be one of the top locations for medical technology, pharma and biotechnology in Germany.

Companies of the German Medical Technology Association BVMed have founded the Cataract Initiative an information platform for patients and other interested parties that provides information on the benefits of modern intraocular lenses.